United Kingdom

People: Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

16 Aug 2019
Change (% chg)

$1.19 (+1.39%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Oesterle, Stephen 

Dr. Stephen N. Oesterle, M.D. serves as Independent Director of the Company. Dr. Oesterle is a consultant and provides advisory services to private equity and operating companies in the healthcare industry. From 2002 to 2015, he served as a member of the Executive Committee of Medtronic (Medtronic), a global medical technology, services and solutions company, and as Senior Vice President, Medicine and Technology of Medtronic. Previously, he served as an Associate Professor of Medicine and Director of Invasive Cardiology Services at each of Massachusetts General Hospital (1998 to 2002), Stanford University Medical Center (1992 to 1998) and Georgetown University Medical Center (1991 to 1992). He served as a director of HeartWare International, Inc. (HeartWare) from January 2016 to November 2016, prior to Medtronic’s acquisition of HeartWare. He served as a director of REVA Medical, Inc. (REVA) from February 2018 through March 2019.Extensive experience in the medical products and healthcare industries with a strong scientific and medical background. Substantial knowledge of the medical device industry and extensive medical and leadership experience as a result of his role as Senior Vice President, Medicine and Technology at Medtronic and as a director at HeartWare and REVA as well as positions held at Harvard Medical School, Stanford University Medical Center and other leading hospitals.

Basic Compensation

Total Annual Compensation, USD 120,000
Restricted Stock Award, USD 185,015
Long-Term Incentive Plans, USD --
All Other, USD 15,085
Fiscal Year Total, USD 320,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jose Almeida


James Saccaro


Brian Stevens


Sean Martin


Jeanne Mason


Giuseppe Accogli

As Of  31 Dec 2018